¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"deficiency anemia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • refractory normoblastic anemia
    ³­Ä¡¼ºÁ¤»óÀûÇ÷¸ð±¸ºóÇ÷
  • spherocytic anemia
    ±¸ÇüÀûÇ÷±¸ºóÇ÷
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷, °â»óÀûÇ÷±¸ºóÇ÷
  • sideroblastic anemia
    öÀûÇ÷¸ð±¸ºóÇ÷
  • target cell anemia
    Ç¥Àû¼¼Æ÷ºóÇ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • microdrepanocytic anemia
    ÀÛÀº³´ÀûÇ÷±¸ºóÇ÷
  • miner's anemia
    ±¤ºÎºóÇ÷
  • mountain anemia
    °í»êºóÇ÷
  • neonatal anemia
    ½Å»ý¾ÆºóÇ÷
  • normoblastic refractory anemia
    Á¤»óÀûÇ÷¸ð±¸Áö¿¬¹ÝÀÀºóÇ÷
  • normochromic anemia
    Á¤»ó»ö¼ÒºóÇ÷
  • normochromic unresponsive anemia
    Á¤»ó»ö¼ÒÁö¿¬¹ÝÀÀºóÇ÷
  • normocytic anemia
    Á¤»óÀûÇ÷±¸ºóÇ÷
  • normovolemic anemia
    Á¤»óÇ÷·®ºóÇ÷
  • pernicious anemia
    ¾Ç¼ººóÇ÷
  • physiological anemia
    »ý¸®ÀûºóÇ÷
  • posthemorrhagic anemia
    ÃâÇ÷ÈĺóÇ÷
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷
  • sideroblastic anemia
    öÀû¸ð±¸ºóÇ÷
  • spherocytic anemia
    ±¸ÇüÀûÇ÷±¸ºóÇ÷, ±¸»óÀûÇ÷±¸ºóÇ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Fanconi anemia
    ÆÇÄÚ´Ï ºóÇ÷
  • Fanconis anemia
    ÆÇÄڴϺóÇ÷
  • Mediterranean anemia
    ÁöÁßÇØºóÇ÷.
  • achlorhydric anemia
    ¹«À§»ê¼º ºóÇ÷(¡­àõÞ¸úì).
  • acute hemolytic anemia
    ±Þ¼º ¿ëÇ÷¼º ºóÇ÷(¡­éÁúìàõÞ¸úì).
  • acute hemolytic anemia
    ±Þ¼º ¿ëÇ÷¼º ºóÇ÷(?ËíÌ´ËÛË×Ì´).
  • acute posthemorrhagic anemia
    ±Þ¼º ÃâÇ÷Èļº ºóÇ÷(¡­õóúìý­àõÞ¸úì).
  • acute posthemorrhagic anemia
    ±Þ¼º ÃâÇ÷Èļº ºóÇ÷(?̴̷̧ËÛË×Ì´).
  • alimentary anemia<³ª> anaemia alimentria
    ½Ä»ç¼º ºóÇ÷(?Ë×Ì´).
  • anemia
    ºóÇ÷
  • anemia aplastic
    Àç»ýºÒ·®¼º ºóÇ÷, ¹«Çü¼º ºóÇ÷.
  • anemia expert system
    ºóÇ÷Àü¹®°¡½Ã½ºÅÛ
  • anemia hemolytic
    ¿ëÇ÷¼º ºóÇ÷.
  • anemia megaloblastic
    °Å´ëÀû¾Æ±¸¼º ºóÇ÷.
  • anemia pernicious
    ¾Ç¼ººóÇ÷.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • disaccaridase deficiency
    ÀÌ´çºÐÇØÈ¿¼Ò°áÇÌ(ì£ÓØÝÂú°ý£áÈÌÀù¹)
  • disaccharidase deficiency
    ÀÌ´ç·ùºÐÇØÈ¿¼Ò°áÇÌÁõ
  • disaccharide deficiency
    ÀÌź´ç°áÇÌ
  • dissacharidase deficiency syndrome
    ÀÌ´ç·ùºÐÇØÈ¿¼Ò °áÇÌÁõÈıº(¡­ÌÀù¹ñøý¦ÏØ ).
  • electrolyte deficiency syndrome
    ÀüÇØÁú °áÇÌÁõÈıº(ï³ú°òõÌÀù¹ñøý¦ÏØ).
  • enzyme deficiency
    È¿¼Ò°áÇÌ(Áõ)
  • erythrocyte enzyme deficiency
    ÀûÇ÷±¸È¿¼Ò°áÇÌÁõ
  • factor deficiency
    Á¦ÀÎÀÚ°áÇÌÁõ(ð¯ì×í­ÌÀù¹ñø).
  • factor ix deficiency
    Á¦9ÀÎÀÚ °áÇÌ(Áõ)
  • factor viii deficiency
    Á¦8ÀÎÀÚ °áÇÌ(Áõ)
  • factor viii-vwf complex deficiency
    Á¦8-vWF º¹ÇÕ °áÇÇ
  • familial apolipoprotein CII deficiency
    °¡Á·¼º ¾ÆÆ÷Áö¹æ´Ü¹é CII °áÇÌÁõ
  • fat deficiency disease
    Áö¹æ°áÇÌÁõ.
  • folate deficiency
    ¿±»ê°áÇÌ(ç¨ß«ÌÀù¹)
  • folic acid deficiency
    ¿±»ê°áÇÌÁõ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
RARS Refractory Anemia with Ringed Sideroblast
  = AISA
SA   1) Sideroblastic Anemia
  2) Sino-Atrial
SAA   1) Severe Aplastic Anemia
  2) Serum Amyloid A protein
XLSA X-Linked Sideroblastic Anemia
AA abdominal aorta; acetic acid; achievement age; active alcoholic; active assistive [range of motion];...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
BLAD Bovine Leukocyte Adhesion Deficiency
CPHD Combined pituitary hormone deficiency
CVID Common Variable Immuno-Deficiency
EFAD Essential fatty acid deficiency
GH-D GH deficiency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • osteosclerotic anemia
    °ñ °æÈ­¼º ºóÇ÷
  • pernicious anemia
    ¾Ç¼º ºóÇ÷
    Ç÷¾× ¼Ó¿¡ °Å´ë Àû¾Æ±¸, °Å´ë ÀûÇ÷±¸°¡ ´Ù¼ö ³ªÅ¸³ª´Â ºóÇ÷·Î¼­ ¼Ò¾Æ¿¡°Ôµµ ³ªÅ¸³ªÁö¸¸ ÀϹÝÀûÀ¸·Î ¼ºÀο¡°Ô ³ªÅ¸³ª¸ç, È÷½ºÅ¸¹Î ³»¼ºÀÇ À§»ê °áÇÌÁõÀ» Ư¡À¸·Î ÇÑ´Ù. ÀÌ °æ¿ì¿¡ °Ë»ç ¼Ò°ß°ú ÀÓ»ó Áõ»óÀº À§ Á¡¸·ÀÌ ÀûÀýÇϰí À¯È¿ÇÑ ³»ÀÎÀÚ¸¦ ºÐºñÇÏÁö ¸øÇÏ¿© ºñŸ¹Î B12°¡ Àß Èí¼öµÇÁö ¸øÇÏ´Â °ÍÀÌ ±Ùº» ¿øÀÎÀÌ´Ù.
  • physiological anemia
    »ý¸®Àû ºóÇ÷
  • plasma thromboplastin antecedent deficiency
    PTA °áÇÌÁõ
  • poikilocytic anemia
    º¯Çü ÀûÇ÷±¸¼º ºóÇ÷, ÀÌÇü ÀûÇ÷±¸¼º ºóÇ÷
  • pyridoxine deficiency
    ÇǸ®µ¶½Å °áÇÌ
  • salt deficiency
    ¿°·ù °áÇÌ
  • secondary anemia
    ¼Ó¹ß¼º ºóÇ÷
  • sickle cell anemia
    °â»ó ÀûÇ÷±¸ ºóÇ÷
    À¯Àü¼ºÀÇ ¿ëÇ÷¼º ºóÇ÷·Î¼­ ÀÌ»ó Ç÷»ö¼ÒÁõÀÇ ÇϳªÀ̸ç ÈæÀο¡°Ô¼­ ÁÖ·Î ³ªÅ¸³ª°í Ç÷¾×¿¡ °â»ó ÀûÇ÷±¸°¡ ÀÖ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù.
  • sickle-cell anemia
    °â»ó ÀûÇ÷±¸ ºóÇ÷
    À¯ÀüÀûÀ¸·Î Çì¸ð±Û·Îºó º£Å¸ ±Û·Îºó chainÀÌ valineÀ¸·Î ¹Ù²î¾î ³´ ¸ð¾çÀÇ ÀûÇ÷±¸¸¦ »ý¼ºÇÏ´Â »óÅÂ. ÈæÀο¡°Ô¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù.
  • sideroblastic refractory anemia
    ö Àû¸ð±¸¼º ºÒÀÀ¼º ºóÇ÷
  • sideropenic anemia
    ö °áÇ̼º ºóÇ÷
    µ¿ÀǾî=iron deficiency anemia. 1. Ç÷ÀåÀÇ Ã¶ºÐÀÌ Àú³óµµÀÎ °ÍÀ» Ư¡À¸·Î ÇÏ´Â ºóÇ÷, ö °áÇ̼º ºóÇ÷°ú ¸¸¼º ºóÇ÷µµ Æ÷ÇÔÇÑ´Ù. 2. ö °áÇ̼º ºóÇ÷Àº °¡Àå ÈçÇÑ Áúȯ Áß Çϳª·Î ¿ù°æ ÃâÇ÷·Î ÀÎÇØ ÀþÀº ¿©¼ºµé¿¡¼­ ÁÖ·Î °üÂûµÈ´Ù. ºóÇ÷Àº Á¶Á÷ ³» »ê¼Ò °ø±ÞÀÇ ºÎÁ·À» ÃÊ·¡Çϸç, ö °áÇ̼º ºóÇ÷À̶õ ¿©·¯ ¿øÀο¡ ÀÇÇØ ü³» ÀúÀå öÀÌ ÇÊ¿äÇÑ ¾çº¸´Ù ºÎÁ·ÇÏ¿© ÀûÇ÷±¸ »ý¼º¿¡ Àå¾Ö°¡ ¹ß»ýÇÏ¿© ÃÊ·¡µÈ´Ù. ¿øÀÎÀ¸·Î´Â °í±â µî öºÐÀÌ µé¾îÀÖ´Â À½½ÄÀÇ ¼·Ãë ºÎÁ·À̳ª À§ ÀýÁ¦¼úÀ» ¹ÞÀº °æ¿ì À§»êÀÇ ºÎÁ·À¸·Î ö Èí¼ö°¡ ºÎÁ·ÇÑ °æ¿ì, ¼ºÀå±â ¾î¸°ÀÌ¿Í Ã»¼Ò³â µî üÁß Áõ°¡¿¡ µû¸¥ ¿ä±¸·®ÀÇ Áõ°¡, ÀӽŠÁßÀÇ ¿©¼º¿¡¼­ žƿ¡ °ø±Þ, ÅÂ¹Ý ¹× Ãâ»ê ½ÃÀÇ ÃâÇ÷, »ý¸®Àû ÀûÇ÷±¸ÀÇ ÃÑ·® Áõ°¡ µîÀÇ ÀÌÀ¯·Î öºÐÀÇ ¿ä±¸·®ÀÌ Áõ°¡ÇÑ´Ù. À§ ±Ë¾ç, Ä¡Áú, Á¾¾ç µî ¸¸¼ºÀûÀÎ À§ Àå°ü ÃâÇ÷À̳ª ¿ù°æ µîÀÇ ¸¸¼ºÀûÀÎ ÃâÇ÷·Î ö ¼Õ½ÇÀÌ Áõ°¡µÇ´Â °æ¿ì ö °áÇ̼º ºóÇ÷ÀÌ ÃÊ·¡µÈ´Ù. Áõ»óÀº ÇǺΰ¡ â¹éÇϸç ź·ÂÀÌ ¼Ò½ÇµÇ°í ¼Õ±ÝÀÇ ÇÎÅ©»öÀÌ ¼Ò½ÇµÇ±âµµ ÇÑ´Ù. ¼ÕÅé¿¡ ±¤ÅÃÀÌ ¼Ò½ÇµÇ°í ºÎ¼­Áö±â ½¬¿ì¸ç ¿À¸ñÇÏ°Ô º¯ÇüµÈ´Ù. ÇÇ·Î, µÎÅë, Çö±âÁõ, ½Ç½Å, ±Ù·ÂÀÇ ÀúÇÏ, ºÒ¾È, È£Èí °ï¶õ, ºó¸Æ, ºÎÁ¾ µîÀ» ÃÊ·¡Çϱ⵵ ÇÑ´Ù. ¶ÇÇÑ ½Ä¿å ºÎÁø, ±¸Åä, º¹ºÎ ºÒÄè°¨, º¯ºñ, ¼³»ç¸¦ ÃÊ·¡ÇÒ ¼öµµ ÀÖ´Ù. °Ë»ç´Â ±âº» °Ë»ç·Î Ç÷»ö¼Ò¿Í Ç츶ÅäÅ©¸´, ¸Á»ó±¸, ¸»ÃÊÇ÷¾× µµ¸» °Ë»ç, Ç÷Áß Ã¶ ¹× ö °áÇÕ´É, ÀúÀå öÀ» ¹Ý¿µÇÏ´Â ÈѸ®Æ¾, ´ëº¯ÀáÇ÷ ¹ÝÀÀ°Ë»ç µîÀÌ ÀÖ´Ù. ƯÈ÷ ö °áÇÌÀº Çö»óÀ̹ǷΠ±Ùº»ÀûÀÎ ¿øÀÎÀÇ Á¦°Å°¡ ÇÊ¿äÇѵ¥ ¿ù°æ·Â¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ¹®ÁøÀÌ ÇÊ¿äÇÏ´Ù. ³²ÀÚ¿¡¼­ ö °áÇ̼º ºóÇ÷ÀÌ ³ªÅ¸³ª°Å³ª ȤÀº ¿©ÀÚ¿¡¼­µµ 40¼¼ À̻󿡼­ ³ªÅ¸³ª´Â °æ¿ì´Â À§ ³»½Ã°æÀ» ºñ·ÔÇÑ À§ Àå°ü °Ë»ç°¡ ÇÊ¿äÇÏ´Ù. ±× Ä¡·á´Â ö °áÇ̼º ºóÇ÷À» ÃÊ·¡ÇÑ ¿øÀÎÀ» ¹àÇô³»°í À̸¦ Ä¡·áÇØ¾ß Çϸç, ºóÇ÷À» ±³Á¤ÇÏ°í ºÎÁ·ÇÑ Ã¼³» ÀúÀå öÀ» ÃæÁ·½ÃÄÑ¾ß ÇÑ´Ù. ºÎÀûÀýÇÑ ½Ä»ç°¡ ¿øÀÎÀ̶ó¸é À̸¦ ±³Á¤ÇÏ°í ±ÕÇüµÈ ½Ä»ç¸¦ Çϵµ·Ï ÇÑ´Ù. ±×·¯³ª ½ÄÀÌ ¿ä¹ý ´Üµ¶À¸·Î ö °áÇ̼º ºóÇ÷ÀÌ ±³Á¤µÇÁö´Â ¾Ê´Â´Ù. °æ±¸¿ë öºÐ Á¦Á¦°¡ ¸¹ÀÌ ÀÖÀ¸³ª ºñŸ¹Î ¾¾¸¦ ÇÔÀ¯ÇÑ Á¦Á¦´Â Èí¼öÀ² Áõ°¡ÀÇ È¿°ú¿¡ ºñÇØ °¡°ÝÀÌ ºñ½Î°í À§Àå Àå¾Ö¸¦ ÁÙÀ̱â À§ÇÑ Àå¿ëÁ¤Àº Èí¼öÀ²ÀÌ ³·´Ù. Ä¡·á ±â°£Àº Ç÷»ö¼Ò°¡ Á¤»óÈ­ÇÑ ÈÄ ¾à 6°³¿ù ÀÌ»ó ´õ º¹¿ëÇØ¾ß ü³» ÀúÀå öÀ» ÃæÁ·½Ãų ¼ö ÀÖ´Ù. ö °áÇ̼º ºóÇ÷Àº ¸Å¿ì ÈçÇÑ ÁúȯÀ̸ç Ä¡·á°¡ ÀÚÁÖ ½ÇÆÐÇÏ´Â ÁúȯÀ¸·Î ±× ÁÖµÈ ½ÇÆÐ ¿øÀÎÀº ÃæºÐÇÑ ±â°£µ¿¾È öºÐ Á¦Á¦¸¦ º¹¿ëÇÏÁö ¾Ê´Âµ¥ ÀÖ´Ù.
  • splenic anemia
    ºñ¼º ºóÇ÷
  • sulfatase deficiency
    ¼³ÆÄÅ×À̽º °áÇÌ
  • symptomatic anemia
    ÁõÈļº ºóÇ÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
proximal femoral focal deficiency A congenital defect in which variable portions of the upper end of the femur are reduced or absent.
(05 Mar 2000)
pseudocholinesterase deficiency An autosomal dominant disorder manifested by exaggerated responses to drugs ordinarily hydrolyzed by serum pseudocholinesterase (e.g., succinylcholine); believed to entail production of a variant enzyme that is less active than the normal enzyme in hydrolyzing appropriate substrates, but also abnormally resistant to the effects of anticholinesterases.
(05 Mar 2000)
secondary antibody deficiency Immunodeficiency in which there is no evident defect in the lymphoid tissues, but rather hypercatabolism or loss of immunoglobulins such as occurs in familial idiopathic hypercatabolic hypoproteinaemia or in defects associated with the nephrotic syndrome.
Synonym: secondary agammaglobulinaemia, secondary antibody deficiency, secondary hypogammaglobulinaemia.
(05 Mar 2000)
selective immunoglobulin A deficiency <immunology> An inherited disorder in which there is a markedly reduced or absent IgA, resulting in immature IgA-bearing B-cells.
(05 Mar 2000)
selenium deficiency deficiency of the essential mineral selenium causes keshan disease, a fatal form of cardiomyopathy (disease of the heart muscle) first observed in keshan province in china and since found elsewhere. According to the national academy of sciences, the recommended dietary allowances of selenium are 70 milligrams per day for men and 55 milligrams per day for women. Food sources of selenium include seafoods, some meats such as kidney and liver, and some grains and seeds
(12 Dec 1998)
pyridoxine deficiency A nutritional condition produced by a deficiency of pyridoxine in the diet, characterised by dermatitis, glossitis, cheilosis, and stomatitis. Marked deficiency causes irritability, weakness, depression, dizziness, peripheral neuropathy, and seizures. In infants and children typical manifestations are diarrhoea, anaemia, and seizures. Increasingly recognised as a cause is prolonged therapy with certain medications, among them isoniazid, cycloserine, and l-dopa.
(12 Dec 1998)
pyruvate carboxylase deficiency An autosomal recessive pyruvate metabolism disorder resulting from absent or deficient expression of pyruvate carboxylase activity. Decreased production of oxaloacetate leads to decreased gluconeogenesis, thereby causing fasting hypoglycaemia, lactic acid acidosis, and decreased synthesis of amino acid neurotransmitters. Clinical presentations include acidosis, ataxia, mental retardation; sometimes co-occurs with leigh disease.
(12 Dec 1998)
pyruvate dehydrogenase complex deficiency An autosomal recessive pyruvate metabolism disorder resulting from deficient enzyme activity in one of several proteins of pyruvate dehydrogenase complex, resulting in deficiency of acetyl CoA. Deficiency in acetyl CoA product reduces the synthesis of acetylcholine, thereby causing neurological abnormalities. Clinical presentations include lactic acidosis, mental retardation, and ataxia.
(12 Dec 1998)
pyruvate kinase deficiency A disorder in which there is a deficiency of pyruvate kinase in red blood cells; characterised by haemolytic anaemia varying in degree from one patient to another; autosomal recessive inheritance.
(05 Mar 2000)
hypoxanthine guanine phosphoribosyltransferase deficiency A sex-linked inherited metabolic disorder; complete deficiency results in Lesch-Nyhan syndrome; incomplete deficiency is associated with acute gouty arthritis and renal stones.
(05 Mar 2000)
steroid sulfatase deficiency A form of ichthyosis, due to 3-beta-hydroxysteroidsulfate sulfatase deficiency, that appears at birth or in early infancy and affects males; characterised by scaling predominantly on the neck and trunk but not on the palms and soles; histologically, there is hyperkeratosis, a granular layer in the epidermis, and normal epidermal cell turnover.
Synonym: steroid sulfatase deficiency.
(05 Mar 2000)
niacin deficiency <biochemistry> A niacin deficiency disease (pellagra) caused by improper diet and characterised by skin lesions, gastrointestinal disturbances and nervousness. Depression, dermatitis, dementia and diarrhoea are common symptoms.
(27 Sep 1997)
debrancher deficiency Type of glycogen storage disease, due to deficiency of amylo-1,4-1,6-transglucosidase (brancher enzyme).
Synonym: brancher deficiency glycogenosis, debrancher deficiency.
(05 Mar 2000)
deficiency A lack or defect.
(18 Nov 1997)
deficiency, alpha-1 antitrypsin An inherited disease with little or no production of an important protein, alpha-1 antitrypsin. The lack of this protein leads to damage of various organs, mainly the lung and liver. The disease may become apparent at a very early age or in adulthood, as shortness of breath or liver-related symptoms (jaundice, fatigue, fluid in the abdomen, mental changes, or gastrointestinal bleeding). There are several options for treatment of the lung disease, including replacement of the missing protein. Treatment of the liver disease is a well-timed liver transplant
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á